3-Ethyloxetane-3-carboxylic Acid: Handling & Synthesis Protocol

3-Ethyloxetane-3-carboxylic acid is a versatile oxetane-based carboxylic acid building block widely employed in medicinal chemistry and materials science for the introduction of the strained four-membered ring motif into drug candidates and functional polymers.

Chemical Name

3-Ethyloxetane-3-carboxylic acid

Product SKU

E169267

Core Structural Feature

Quaternary carbon-substituted oxetane ring bearing a free carboxylic acid group

Primary Application

Synthetic building block for drug discovery and polymer chemistry

Ring System

Oxetane (saturated four-membered cyclic ether)

Functional Groups

Carboxylic acid (–COOH) and oxetane ether oxygen

Introduction and Chemical Background

3-Ethyloxetane-3-carboxylic acid belongs to the oxetane family of saturated four-membered cyclic ethers. The oxetane ring has attracted significant attention in modern drug discovery as a bioisostere for gem-dimethyl groups, carbonyl functionalities, and other structural motifs, owing to its ability to improve aqueous solubility, metabolic stability, and physicochemical properties of candidate molecules.

The 3,3-disubstituted substitution pattern in this compound places both an ethyl group and a carboxylic acid on the same quaternary carbon at the 3-position of the ring. This quaternary carbon architecture confers additional conformational rigidity and reduces susceptibility to oxidative metabolism at that centre. The carboxylic acid handle provides a versatile synthetic handle for amide coupling, esterification, and other downstream transformations, making this compound a highly practical intermediate for medicinal chemistry programmes.

In materials science, oxetane-containing monomers are well known as cationically photopolymerisable precursors, and carboxylic acid-functionalised derivatives such as this compound can be exploited to introduce pendant functionality into polymer networks.

Storage, Safety, and Handling

Storage: Store 3-Ethyloxetane-3-carboxylic acid in a tightly sealed container in a cool, dry, and well-ventilated location, away from moisture, strong oxidising agents, and strong bases. Refrigerated storage (2–8 °C) is recommended for long-term preservation of purity. Always check the product certificate of analysis (CoA) supplied with each lot for confirmed storage conditions.

Personal Protective Equipment (PPE): As with all laboratory reagents, wear appropriate PPE including nitrile gloves, safety goggles, and a laboratory coat when handling this compound. Work in a fume hood when weighing or transferring bulk quantities to minimise inhalation exposure to dust.

Waste Disposal: Dispose of waste material in accordance with applicable local, regional, and national regulations. Do not pour solutions of this compound down the drain without confirming compliance with local effluent guidelines. Consult the Safety Data Sheet (SDS) for full hazard classification and first-aid measures before use.

Stability: The compound is stable under recommended storage conditions. The oxetane ring is relatively stable to nucleophilic ring-opening under neutral and mildly basic conditions but may undergo ring-opening in the presence of strong acids or strong Lewis acids; avoid prolonged exposure to such conditions.

Representative Synthetic Protocol: Amide Coupling

The free carboxylic acid of 3-Ethyloxetane-3-carboxylic acid can be directly engaged in standard amide bond-forming reactions. The following general protocol illustrates a coupling with a primary amine using a common carbodiimide-based reagent system.

Materials required:

• 3-Ethyloxetane-3-carboxylic acid (1.0 equiv, SKU E169267)
• Primary or secondary amine coupling partner (1.0–1.2 equiv)
• EDC·HCl (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, 1.2 equiv) or HATU (1.2 equiv)
• HOBt (1-hydroxybenzotriazole, 1.2 equiv) or DIPEA (2.0–3.0 equiv) as appropriate
• Anhydrous DMF or DCM as solvent
• Analytical TLC plates and appropriate UV/staining visualisation

Procedure:

1. Dissolve 3-Ethyloxetane-3-carboxylic acid (1.0 equiv) in anhydrous DMF (0.1–0.5 M) under a nitrogen atmosphere at room temperature.
2. Add the coupling reagent (EDC·HCl or HATU, 1.2 equiv) followed by HOBt (1.2 equiv) or DIPEA (2.0–3.0 equiv). Stir for 10–15 minutes to form the activated ester intermediate.
3. Add the amine coupling partner (1.0–1.2 equiv) and stir the reaction mixture at room temperature, monitoring by TLC or LC-MS until consumption of starting material is observed (typically 1–16 hours depending on amine nucleophilicity).
4. Dilute the reaction mixture with ethyl acetate, wash sequentially with saturated aqueous ammonium chloride, saturated aqueous sodium bicarbonate, and brine. Dry over anhydrous MgSO₄ or Na₂SO₄, filter, and concentrate under reduced pressure.
5. Purify the crude product by silica gel column chromatography or preparative HPLC as appropriate. Confirm product identity and purity by ¹H NMR, ¹³C NMR, and high-resolution mass spectrometry (HRMS).

Note: Reaction times and conditions may vary depending on the specific amine substrate. Optimise base equivalents and temperature empirically for sensitive substrates. The oxetane ring is compatible with these standard coupling conditions.

Analytical Characterisation

Proper characterisation of 3-Ethyloxetane-3-carboxylic acid and its reaction products is essential to confirm identity and purity. The following analytical techniques are recommended:

Nuclear Magnetic Resonance (NMR) Spectroscopy: The oxetane ring protons (–OCH₂– at the 2- and 4-positions) typically appear as two sets of diastereotopic AB quartet signals in the ¹H NMR spectrum (commonly in the range δ 4.4–4.7 ppm in CDCl₃). The carboxylic acid proton resonates broadly around δ 10–12 ppm. The ethyl group presents as a triplet (–CH₂–) and quartet (–CH₃) pattern. ¹³C NMR should confirm the quaternary carbon at the 3-position (typically δ 38–42 ppm), the carboxylic acid carbonyl (δ ~175 ppm), and the two oxetane methylene carbons (δ ~79–81 ppm).

Mass Spectrometry: Electrospray ionisation mass spectrometry (ESI-MS) in negative or positive mode can be used to confirm the molecular ion. High-resolution mass spectrometry (HRMS) provides elemental composition confirmation.

Infrared (IR) Spectroscopy: A strong carbonyl stretch for the carboxylic acid C=O is expected around 1700–1720 cm^-1, with a broad O–H stretch in the region 2500–3300 cm^-1. The C–O–C stretching of the oxetane ring appears around 980–1000 cm^-1.

HPLC Purity Analysis: Reverse-phase HPLC (C18 column, water/acetonitrile gradient with 0.1% formic acid or TFA modifier) provides purity assessment. Confirm lot purity against the certificate of analysis (CoA) provided by Aladdin Scientific.

Applications in Drug Discovery and Materials Science

Medicinal Chemistry — Oxetane as a Bioisostere: The oxetane ring system has gained prominence as a versatile bioisostere in drug design. 3,3-Disubstituted oxetanes, as represented by this compound, have been used to replace gem-dimethyl groups, carbonyl functionalities, and other structural elements in lead structures to modulate lipophilicity (logP), improve aqueous solubility, and enhance metabolic stability. The carboxylic acid group in 3-Ethyloxetane-3-carboxylic acid allows straightforward conversion to amides, esters, and other derivatives for SAR exploration.

Fragment-Based Drug Discovery (FBDD): This compound represents a compact, sp³-rich fragment with defined three-dimensional character, making it a suitable candidate for fragment libraries used in FBDD campaigns targeting a range of biological macromolecule targets.

Polymer and Materials Chemistry: Oxetane monomers are established precursors for cationic ring-opening polymerisation (CROP), producing polyethers with tailored properties. Carboxylic acid-substituted oxetane derivatives can be incorporated into polymer backbones or used as chain-end functionalised precursors to introduce reactive handles for post-polymerisation modification.

Prodrug and Linker Chemistry: The carboxylic acid functionality can be exploited in the design of prodrugs or antibody-drug conjugate (ADC) linkers, where the oxetane ring provides a metabolically stable spacer element.

Frequently asked questions

What is 3-Ethyloxetane-3-carboxylic acid used for?

3-Ethyloxetane-3-carboxylic acid is primarily used as a synthetic building block in medicinal chemistry and materials science. Its carboxylic acid group enables amide coupling, esterification, and related transformations, while the oxetane ring serves as a bioisostere or polymerisable motif for improving the physicochemical and metabolic properties of candidate molecules or polymers.

Is the oxetane ring stable under standard amide coupling conditions?

Yes, the oxetane ring in 3-Ethyloxetane-3-carboxylic acid is generally compatible with standard amide coupling conditions employing reagents such as EDC/HOBt or HATU in DMF or DCM at room temperature. However, the ring may be susceptible to acid-catalysed ring-opening under strongly acidic conditions; therefore, prolonged exposure to concentrated strong acids or strong Lewis acids should be avoided.

How should 3-Ethyloxetane-3-carboxylic acid be stored?

The compound should be stored in a tightly sealed container under cool, dry, and well-ventilated conditions, away from moisture and strong oxidising agents. Refrigerated storage at 2–8 °C is recommended for long-term preservation. Always refer to the certificate of analysis (CoA) and safety data sheet (SDS) provided by Aladdin Scientific for lot-specific storage guidance.

What analytical methods are recommended to characterise this compound?

Recommended characterisation methods include 1H and 13C NMR spectroscopy to confirm the oxetane ring, quaternary carbon, and carboxylic acid signals; ESI-MS or HRMS for molecular weight and elemental composition confirmation; IR spectroscopy to identify the carboxylic acid carbonyl and oxetane C–O–C stretches; and reverse-phase HPLC for purity assessment. All results should be compared against the Aladdin Scientific CoA for the respective lot.

References

1. Burkhard, J. A.; Wuitschik, G.; Rogers-Evans, M.; Müller, K.; Carreira, E. M. Oxetanes as Versatile Elements in Drug Discovery and Synthesis. Angewandte Chemie International Edition, 2010, 49, 9052–9067. doi:10.1002/anie.201003763
2. Wuitschik, G.; Rogers-Evans, M.; Müller, K.; Fischer, H.; Wagner, B.; Schuler, F.; Polonchuk, L.; Carreira, E. M. Oxetanes as Promising Modules in Drug Discovery. Journal of Medicinal Chemistry, 2006, 49, 7392–7408. doi:10.1021/jm0609051
3. Aladdin Scientific. Product Certificate of Analysis: 3-Ethyloxetane-3-carboxylic acid, SKU E169267. Aladdin Scientific, Shanghai.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.